Niki BioSolutions launches up to $1.396 million ATM stock program

Niki BioSolutions entered an at-the-market (ATM) offering agreement to sell up to $1.396 million of common stock from time to time through H.C. Wainwright as sales agent, with Brookline Capital Markets acting as qualified independent underwriter due to a conflict. Sales will occur at prevailing mark…